Registration gives the benefit of site update e-mails and additional information from Shire on new education materials and events.
ADHD Institute Register

ADHD across the lifespan tool

ADHD can have a significant social impact on patients’ lives, disrupting education, employment, finances, family life and relationships.

Launch now

2017/2018 ADHD Guidelines

A summary of recommendations for pharmacological treatment from selected guidelines

Download booklet

An interactive guide to the MOA of selected medications used in the treatment of ADHD

This is an MOA of pharmacological treatments only. Pharmacological treatment is not indicated for all patients and it must be used as part of a multimodal treatment approach

Launch now

Expert insight article – Transition in ADHD

Written by Dr Kuben Naidoo

Read now

Guidelines – UPDATE

Clinical guidelines are available to provide evidence-based recommendations for the management of ADHD to help guide appropriate and rational choices of treatment

Read more

Adult ADHD: burden and diagnosis

eLearning module: Adult ADHD: burden and diagnosis

Launch now

ADHD is a lifelong disorder

ADHD is a chronic neurodevelopmental disorder which can affect children, adolescents and adults

Read more

The neurobiology of ADHD
is highly complex

Evidence exists for the association between ADHD and possible structural, functional and neurotransmitter alterations in various regions of the brain in children, adolescents and adults with ADHD

Read more

Assessment and diagnosis

ADHD assessment involves clinical examination, interviews and rating scales. Formal ADHD diagnosis typically utilises DSM-5TM or ICD-10 classification systems

Read more

Optimal management of ADHD

The optimal management of ADHD process should always consider input from the patient, family/caregivers and school to help establish an appropriate and extensive treatment programme (non-pharmacological and pharmacological therapy), goals and assessment/follow-up, resulting in a tailored multimodal treatment plan centred on the patient

Read more

Attention-deficit hyperactivity disorder (ADHD) is a diverse condition characterised by symptoms of inattention, hyperactivity and impulsivity; and can have a significant impact on patients’ lives.3,4 This website provides educational resources intended for healthcare professionals outside the US with an interest in ADHD. It aims to share scientific advances in ADHD research and provide expert opinions and medical education to support the healthcare professional community.

  1. Kooij SJ, Bejerot S, Blackwell A, et al. European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry 2010; 10: 67.
  2. Kooij SJJ, Huss M, Asherson P, et al. Distinguishing comorbidity and successful management of adult ADHD. J Atten Disord 2012; 16 (5 Suppl): 3S-19S.
  3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Washington, DC: American Psychiatric Association, 2013.
  4. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Available at: Last updated 1993; 1: 1-263. Accessed 08 June 2017.
Filter content by:

ADHD Institue logo

You’re now being transferred to

and are leaving the ADHD Institute site

Shire has no influence or control over the content of this third party website.

Continue Cancel